Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

487 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biomarkers for Alzheimer's disease therapeutic trials.
Hampel H, Wilcock G, Andrieu S, Aisen P, Blennow K, Broich K, Carrillo M, Fox NC, Frisoni GB, Isaac M, Lovestone S, Nordberg A, Prvulovic D, Sampaio C, Scheltens P, Weiner M, Winblad B, Coley N, Vellas B; Oxford Task Force Group. Hampel H, et al. Among authors: lovestone s. Prog Neurobiol. 2011 Dec;95(4):579-93. doi: 10.1016/j.pneurobio.2010.11.005. Epub 2010 Dec 2. Prog Neurobiol. 2011. PMID: 21130138 Review.
MRI measures of Alzheimer's disease and the AddNeuroMed study.
Simmons A, Westman E, Muehlboeck S, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Wahlund LO, Soininen H, Lovestone S, Evans A, Spenger C; AddNeuroMed Consortium. Simmons A, et al. Among authors: lovestone s. Ann N Y Acad Sci. 2009 Oct;1180:47-55. doi: 10.1111/j.1749-6632.2009.05063.x. Ann N Y Acad Sci. 2009. PMID: 19906260
Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease.
Liu Y, Paajanen T, Zhang Y, Westman E, Wahlund LO, Simmons A, Tunnard C, Sobow T, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, Soininen H; AddNeuroMed Consortium. Liu Y, et al. Among authors: lovestone s. Neurobiol Aging. 2010 Aug;31(8):1375-85. doi: 10.1016/j.neurobiolaging.2010.01.022. Epub 2010 May 5. Neurobiol Aging. 2010. PMID: 20447732
AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America.
Westman E, Simmons A, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Weiner MW, Lovestone S, Spenger C, Wahlund LO; AddNeuroMed consortium; Alzheimer's Disease Neuroimaging Initiative. Westman E, et al. Among authors: lovestone s. Neuroimage. 2011 Oct 1;58(3):818-28. doi: 10.1016/j.neuroimage.2011.06.065. Epub 2011 Jul 1. Neuroimage. 2011. PMID: 21763442
Combinatorial markers of mild cognitive impairment conversion to Alzheimer's disease--cytokines and MRI measures together predict disease progression.
Furney SJ, Kronenberg D, Simmons A, Güntert A, Dobson RJ, Proitsi P, Wahlund LO, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Spenger C, Lovestone S. Furney SJ, et al. Among authors: lovestone s. J Alzheimers Dis. 2011;26 Suppl 3:395-405. doi: 10.3233/JAD-2011-0044. J Alzheimers Dis. 2011. PMID: 21971479
Plasma biomarkers of brain atrophy in Alzheimer's disease.
Thambisetty M, Simmons A, Hye A, Campbell J, Westman E, Zhang Y, Wahlund LO, Kinsey A, Causevic M, Killick R, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Spenger C, Lovestone S; AddNeuroMed Consortium. Thambisetty M, et al. Among authors: lovestone s. PLoS One. 2011;6(12):e28527. doi: 10.1371/journal.pone.0028527. Epub 2011 Dec 21. PLoS One. 2011. PMID: 22205954 Free PMC article.
A blood gene expression marker of early Alzheimer's disease.
Lunnon K, Sattlecker M, Furney SJ, Coppola G, Simmons A, Proitsi P, Lupton MK, Lourdusamy A, Johnston C, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Geschwind D, Lovestone S, Dobson R, Hodges A; dNeuroMed Consortium. Lunnon K, et al. Among authors: lovestone s. J Alzheimers Dis. 2013;33(3):737-53. doi: 10.3233/JAD-2012-121363. J Alzheimers Dis. 2013. PMID: 23042217
Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease.
Velayudhan L, Proitsi P, Westman E, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Spenger C, Hodges A, Powell J, Lovestone S, Simmons A; dNeuroMed Consortium. Velayudhan L, et al. Among authors: lovestone s. J Alzheimers Dis. 2013;33(3):755-66. doi: 10.3233/JAD-2012-121408. J Alzheimers Dis. 2013. PMID: 23047370
487 results